Form 4 for LGND LIGAND PHARMACEUTICALS INC
Accepted 2025-08-05 00:00:00 ET · period of report 2025-08-01 · accession 0002001011-25-000059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-05 | 2025-08-01 | LGND | KOZARICH JOHN W | Dir | S - Sale | $131.88 | -467 | 46.0K | -1% | -$61.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-01 | S | D | 467 | $131.88 | 45,989 | D | — | — | (F1) The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1. |